Allianz Asset Management GmbH Increases Stock Position in Bath & Body Works, Inc. $BBWI

Allianz Asset Management GmbH increased its position in Bath & Body Works, Inc. (NYSE:BBWI) by 43.2% in the 2nd quarter, Holdings Channel.com reports. The firm owned 165,988 shares of the company’s stock after buying an additional 50,072 shares during the quarter. Allianz Asset Management GmbH’s holdings in Bath & Body Works were worth $4,973,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in BBWI. Victory Capital Management Inc. boosted its stake in shares of Bath & Body Works by 14,732.0% in the first quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company’s stock valued at $206,119,000 after purchasing an additional 6,752,274 shares during the period. AQR Capital Management LLC boosted its stake in shares of Bath & Body Works by 267.8% in the first quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock valued at $121,073,000 after purchasing an additional 2,907,506 shares during the period. Fuller & Thaler Asset Management Inc. boosted its stake in shares of Bath & Body Works by 115.7% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company’s stock valued at $111,581,000 after purchasing an additional 1,973,679 shares during the period. T. Rowe Price Investment Management Inc. boosted its stake in Bath & Body Works by 7.6% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock valued at $334,029,000 after acquiring an additional 781,681 shares during the last quarter. Finally, Nuveen LLC bought a new position in Bath & Body Works during the 1st quarter valued at $23,273,000. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

BBWI has been the topic of a number of research analyst reports. Jefferies Financial Group reduced their price objective on shares of Bath & Body Works from $32.00 to $28.50 and set a “hold” rating on the stock in a research note on Monday, October 13th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $26.00 price objective on shares of Bath & Body Works in a research note on Monday, October 6th. Barclays reduced their price objective on shares of Bath & Body Works from $32.00 to $28.00 and set an “equal weight” rating on the stock in a research note on Monday. Telsey Advisory Group reiterated an “outperform” rating and set a $38.00 price objective on shares of Bath & Body Works in a research note on Thursday, August 28th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, October 8th. Eleven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Bath & Body Works has a consensus rating of “Moderate Buy” and a consensus target price of $37.18.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI opened at $27.03 on Friday. The stock has a market capitalization of $5.57 billion, a price-to-earnings ratio of 8.02, a price-to-earnings-growth ratio of 0.90 and a beta of 1.52. Bath & Body Works, Inc. has a 1-year low of $24.85 and a 1-year high of $41.87. The company’s fifty day moving average is $27.54 and its two-hundred day moving average is $29.05.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.37. The company had revenue of $1.55 billion for the quarter, compared to analysts’ expectations of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm’s revenue was down .8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works’s dividend payout ratio (DPR) is 23.74%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.